Cargando…

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia

PURPOSE: To evaluate the efficacy and safety of 500 mg of nemonoxacin administered orally once daily to outpatients with community-acquired pneumonia (CAP). PATIENTS AND METHODS: Patients with CAP who received nemonoxacin monotherapy were selected from outpatients who visited the Department of Pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Bo, Yu, Xiaoxu, Chen, Rui, Zheng, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337426/ https://www.ncbi.nlm.nih.gov/pubmed/32669862 http://dx.doi.org/10.2147/IDR.S248092

Ejemplares similares

The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
por: Chang, Shen-Peng, et al.
Publicado: (2019)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
por: Chen, Yuancheng, et al.
Publicado: (2023)

Safety and Efficacy of Nemonoxacin vs Levofloxacin in Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Control Trials
por: Khan, Alina S, et al.
Publicado: (2023)

Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis
por: Zhao, Mingye, et al.
Publicado: (2022)

Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers
por: Zhang, Yi-fan, et al.
Publicado: (2016)

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
por: Yuan, Jinyi, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
por: Li, Xin, et al.
Publicado: (2021)

Review of nemonoxacin with special focus on clinical development
por: Qin, Xiaohua, et al.
Publicado: (2014)

In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone
por: Roychoudhury, Siddhartha, et al.
Publicado: (2016)

The prevalence of respiratory pathogens in adults with community-acquired pneumonia in an outpatient cohort
por: Chen, Jing, et al.
Publicado: (2019)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

Community-acquired pneumonia complicated by rhabdomyolysis: A clinical analysis of 11 cases
por: Zhao, Bo, et al.
Publicado: (2019)

Recent Advances in Community-Acquired Pneumonia: Inpatient and Outpatient
por: Niederman, Michael S.
Publicado: (2007)

Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease
por: Meng, Weiwei, et al.
Publicado: (2023)

Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
por: Saatchi, Ariana, et al.
Publicado: (2023)

1465. Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
por: Wattengel, Bethany, et al.
Publicado: (2018)

1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia
por: Mergenhagen, Kari, et al.
Publicado: (2018)

Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: A meta-analysis
por: Jiang, Shan, et al.
Publicado: (2019)

COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA
por: Ige, O.M., et al.
Publicado: (2015)

Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin
por: Kocsis, Bela, et al.
Publicado: (2016)

Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever
por: Luan, Ying, et al.
Publicado: (2018)

Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)
por: Kuzman, Ilija, et al.
Publicado: (2014)

Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)

The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model
por: Lodise, Thomas P., et al.
Publicado: (2020)

Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults
por: Saatchi, Ariana, et al.
Publicado: (2023)

Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China
por: Liu, Ya-Fen, et al.
Publicado: (2013)

Community-acquired pneumonia in children
por: Davies, H Dele
Publicado: (2003)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

In vitro Activities of Nemonoxacin and Other Antimicrobial Agents Against Human Mycoplasma and Ureaplasmas Isolates and Their Defined Resistance Mechanisms
por: Wang, Na, et al.
Publicado: (2019)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Community-acquired pneumonia
por: Niederman, Michael S.
Publicado: (2010)

Community-Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2017)

Community‐Acquired Pneumonia
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_j7gb5ql6le0r5g7t4v9sse4ark